Dr Oliver Treacy

Junior Council Member

Dr Oliver Treacy is a Postdoctoral Researcher in the Regenerative Medicine Institute (REMEDI) and Discipline of Pharmacology and Therapeutics based at NUI, Galway (NUIG).

He obtained his BSc (Hons) in Microbiology in 2005 and MSc in Regenerative Medicine in 2009 from NUIG. Prior to completing his Master’s degree, he worked for Abbott Ireland (Diagnostics Division) based in Co. Sligo. Following completion of his Master’s degree, he pursued a PhD in transplant immunology investigating the ability of mesenchymal stromal cells (MSCs) to prolong corneal allograft survival. He graduated from NUIG with his degree in 2014. Oliver continued his work in the area of transplant immunology in a Postdoctoral position funded by SFI, with a focus on enhancing the therapeutic efficacy of MSCs through licensing.

In 2017, he joined the lab of Dr Aideen Ryan on a SFI-funded project aimed at identifying novel stromal cell-related immunotherapeutic targets for the treatment of metastatic colon cancer The focus of his current work is to investigate the role of stromal cell-derived programmed death-ligand 1 (and other immune checkpoint markers) in the context of colon cancer development and metastasis.

Back to Governance

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Find Out More

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Donate to Cancer Research

All donations to the IACR go directly towards supporting early-stage oncology scientific researchers in their work.

Donate Now

IACR 2023 Carer’s Bursary €300

Apply for funding towards additional costs of care while attending conference. Five Bursaries Available.

Find Out More

Registration/ Membership for IACR 2023

Registration for the 59th Annual Conference in the Radisson Blu hotel, Athlone is Now Open.

EACR Membership is Included

The IACR is an affiliated national society and its members benefit from full membership of the EACR.

See EACR Benefits

Biomedical Session Abstracts

Deadline: Midnight, Friday, 20th January 2023

Please note:
- Patrick Johnston Lay submission category is now closed
- Late Breaking Abstracts submitted to the Biomedical Sessions will be considered for Display Poster Presentation.

Social Nursing and Allied Health (SNAH) Abstracts

Deadline: Midnight, Monday, 9th January 2023

SNAH abstract submissions will remain open until Monday 9th January.

Any questions?
Please contact Sinead on: sinead@sineadcassidy.com